Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy of the thyroid C cells.
Metastatic spread commonly occurs to cervical and mediastinal lymph nodes. MTC cells do …

Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy of the thyroid C cells
that occurs in hereditary and sporadic clinical settings. Metastatic spread commonly occurs …

Medullary thyroid carcinoma (MTC) originates from the parafollicular C cells of the thyroid
and accounts for roughly 5% of all differentiated types of thyroid cancer. Among …

Medullary thyroid carcinoma (MTC) is a prototype disease in the rapidly emerging field of
molecular endocrine oncology. Since its recognition in 1959, MTC has distinguished itself …

Opinion statement Patients with clinically evident medullary thyroid cancer should have a
total extracapsular thyroidectomy with bilateral central neck dissection and an ipsilateral …

Objective This review outlines advances in the diagnosis, genetic testing, and progress in
medullary thyroid cancer (MTC) treatment in light of the most recent evidence. Methods …

Abstract Learning Objectives After completing this course, the reader will be able to:
Evaluate a patient with a new diagnosis of medullary thyroid cancer. Use genetic testing for …

Medullary thyroid carcinoma (MTC) is a rare malignancy of the thyroid C cells. It occurs in
hereditary (25% of cases) and sporadic (75%) forms. Sporadic MTCs frequently metastasize …

Prognosis and treatment effectiveness of medullary thyroid carcinoma (MTC) are largely
related to the tumour stage, so that early diagnosis represents an important goal for the …

Background: Because medullary thyroid carcinoma accounts for only 7% of all thyroid
malignancies, data to support treatment strategies are scarce. Methods: We retrospectively …